Serum proteomic profiling in patients with drug-induced liver injury

Review article: drug-induced liver injury in clinical practice

(2015) E. Björnsson   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: drug-induced liver injury - its pathophysiology and evolving diagnostic tools

(2011) J. S. Au et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Clinical and Histopathologic Features of Fluoroquinolone-Induced Liver Injury

(2011) Eric S. Orman et al.   Clinical Gastroenterology and Hepatology

Mechanisms of drug-induced liver injury: from bedside to bench

(2011) Shannan Tujios et al.   Nature Reviews Gastroenterology & Hepatology

Duloxetine hepatotoxicity: a case-series from the drug-induced liver injury network

(2010) R. Vuppalanchi et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

The Application of Metabonomics to Predict Drug-Induced Liver Injury

(2010) T M O'Connell et al.   CLINICAL PHARMACOLOGY & THERAPEUTICS

The potential of cytokines as safety biomarkers for drug-induced liver injury

(2010) Hugh G. Laverty et al.   EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY

Risk Factors for Idiosyncratic Drug-Induced Liver Injury

(2010) Naga Chalasani et al.   GASTROENTEROLOGY

Causality assessment in drug-induced liver injury using a structured expert opinion process: Comparison to the Roussel-Uclaf causality assessment method

(2010) Don C. Rockey et al.   HEPATOLOGY

Drug-induced acute liver failure: Results of a U.S. multicenter, prospective study

(2010) Adrian Reuben et al.   HEPATOLOGY

Potential Implications for Monitoring Serum Bile Acid Profiles in Circulation with Serum Proteome for Carbon Tetrachloride-Induced Liver Injury/Regeneration Model in Mice

(2010) Takashi Shimada et al.   JOURNAL OF PROTEOME RESEARCH

Analysis of Secreted Proteins as anin vitroModel for Discovery of Liver Toxicity Markers

(2010) John A. Lewis et al.   JOURNAL OF PROTEOME RESEARCH

Use of transcriptomics in understanding mechanisms of drug-induced toxicity

(2010) Yuxia Cui et al.   PHARMACOGENOMICS

Plasma and liver proteomic analysis of 3Z-3-[(1H-pyrrol-2-yl)-methylidene]-1-(1-piperidinylmethyl)-1,3-2H-indol-2-one-induced hepatotoxicity in Wistar rats

(2010) Ying Wang et al.   PROTEOMICS

The enhanced value of combining conventional and “omics” analyses in early assessment of drug-induced hepatobiliary injury

(2010) Heidrun Ellinger-Ziegelbauer et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Application of toxicogenomics in hepatic systems toxicology for risk assessment: Acetaminophen as a case study

(2010) Anne S. Kienhuis et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Increased susceptibility to exacerbated liver injury in hypercholesterolemic ApoE-deficient mice: potential involvement of oxysterols

(2009) Natàlia Ferré et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A systems biology approach to understanding elevated serum alanine transaminase levels in a clinical trial with ximelagatran

(2009) Ulf Andersson et al.   BIOMARKERS

Drug-Induced Liver Injury Network (DILIN) Prospective Study

(2009) Robert J. Fontana et al.   DRUG SAFETY

Serum proteomics and biomarker discovery across the spectrum of nonalcoholic fatty liver disease

(2009) Lauren N. Bell et al.   HEPATOLOGY

Causes, Clinical Features, and Outcomes From a Prospective Study of Drug-Induced Liver Injury in the United States

(2008) Naga Chalasani et al.   GASTROENTEROLOGY